PRKAA1 and liver cancer: Since activation of fatty acid oxidation and inhibition of fatty acid synthesis are two of the classical effects of AMPK [11], while AMPK can also act as a tumor suppressor, down-regulation of AMPK by HCV may help to explain the increased risk of both fatty liver disease and liver cancer.